OEDIT Grant Award

Published:
November 21, 2019

We are proud to announce that on Nov 21, 2019, Colorado’s Office of Economic Development & International Trade (OEDIT)’s Advanced Industries Accelerator Program announced that BioLoomics was awarded a $240,000 Early Stage Capital Retention Grant. We are grateful for the support from the State of Colorado, and look forward to growing our company and ultimately creating more Advanced Industry jobs in Colorado. 

The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries that drive the State’s economic growth. 

Written by

View More News

BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

October 15, 2024

BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs

Former CSO of Trilo Therapeutics and Research Fellow atAbbVie joins to lead BioLoomics’ pipeline and combine lysosome targetingantibodies with ADCs

October 15, 2024
View News Article

Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders

June 13, 2024

Backed by former Google CEO’s VC, a Colorado biotech hatches platform to evolve degraders

BioLoomics’ goal is to make a degrader from an antibody in one month

June 13, 2024
View News Article

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

June 13, 2024

BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies

Our mission is to make safer, more effective cancer therapeutics.

June 13, 2024
View News Article

Pre-Seed Extension

June 13, 2024

Pre-Seed Extension

BioLoomics closed a $575,000 round of pre seed extension funding on May 11, 2021..

June 13, 2024
View News Article

OEDIT Grant Award

June 13, 2024

OEDIT Grant Award

The Colorado OEDIT provides funding opportunities to small businesses in fourteen industries...

June 13, 2024
View News Article

BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform

June 13, 2024

BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform

We are excited to announce that on May 30, 2019, BioLoomics closed a $600,000 pre-seed round...

June 13, 2024
View News Article
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.